{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:59:03Z","timestamp":1787961543070,"version":"build-2784847793"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100031558","name":"Corporaci\u00f3n Universitaria Empresarial Alexander von Humboldt","doi-asserted-by":"publisher","award":["D.I.M.05-2022"],"award-info":[{"award-number":["D.I.M.05-2022"]}],"id":[{"id":"10.13039\/100031558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031558","name":"Corporaci\u00f3n Universitaria Empresarial Alexander von Humboldt","doi-asserted-by":"publisher","award":["D.I.M.03-2024"],"award-info":[{"award-number":["D.I.M.03-2024"]}],"id":[{"id":"10.13039\/100031558","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Chagas disease, caused by the protozoan parasite <jats:italic>Trypanosoma cruzi<\/jats:italic>, is a neglected tropical illness affecting an estimated 6\u20137 million people worldwide. The currently approved drugs have significant limitations, but antimicrobial peptides (AMPs) have emerged as promising therapeutic alternatives. Members of the cruzioseptin family, a group of AMPs derived from the frog <jats:italic>Cruziohyla calcarifer<\/jats:italic>, have demonstrated anti-<jats:italic>T. cruzi<\/jats:italic> activity, but their mode of action remains poorly understood. Herein, <jats:italic>T. cruzi<\/jats:italic> epimastigotes were used to identify active cruzioseptins and investigate their mechanism of action through untargeted metabolomics and molecular dynamics simulations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Synthetic versions of three previously unstudied cruzioseptins (CZS-5, CZS-7, and CZS-11) were evaluated for their effects on <jats:italic>T. cruzi<\/jats:italic> X-1081 epimastigotes via microplate assays with resazurin-based viability measurements. CZS-1, a peptide with known anti-<jats:italic>T. cruzi<\/jats:italic> activity, was also included. Selectivity was assessed via hemolysis assays on human erythrocytes. To evaluate membrane damage, DNA leakage assays and scanning electron microscopy (SEM) were performed on epimastigotes treated with CZS-5. In addition, the interaction of cruzioseptins with the epimastigote membrane was modeled using molecular dynamics simulations. To explore additional mechanisms of action, a multiplatform metabolomic analysis (HILIC-LC-QTOF-MS and GC-QTOF-MS) was conducted to identify altered metabolites in epimastigotes treated with CZS-5.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among the tested cruzioseptins, CZS-5 exhibited the highest potency (IC<jats:sub>50<\/jats:sub>\u2009=\u20094.7\u2009\u00b1\u20091.0\u00a0\u00b5M) and selectivity (SI\u2009=\u200950.3). This peptide induced DNA leakage from epimastigotes and caused surface alterations, suggesting membrane damage. Molecular dynamics simulations indicated that CZS-5 may exert its effects through the formation of toroidal pores in the parasite membrane. Untargeted metabolomic analysis revealed 118 altered metabolites in CZS-5-treated epimastigotes, with significant enrichment of glycerophospholipids (40.7%), supporting the involvement of membrane disruption. In addition, metabolic pathways were affected, suggesting complementary mechanisms of action, including oxidative stress and disruptions in energy metabolism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>CZS-5 was identified as a potent cruzioseptin with multiple potential mechanisms of action in the epimastigotes stage of <jats:italic>T. cruzi<\/jats:italic>. Further validation is needed in clinically relevant parasite stages to assess its potential as a therapeutic agent.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13071-025-06861-5","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T07:23:34Z","timestamp":1749108214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploring the mechanisms of action of the antimicrobial peptide CZS-5 against Trypanosoma cruzi epimastigotes: insights from metabolomics and molecular dynamics"],"prefix":"10.1186","volume":"18","author":[{"given":"Juan Felipe","family":"Osorio-M\u00e9ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pardo-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Rocha-Roa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily Johana","family":"Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mu\u00f1oz-Tabares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia Piedad","family":"Recalde-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica P.","family":"Cala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"6861_CR1","unstructured":"WHO. Chagas disease. 2014. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chagas-disease-(american-trypanosomiasis. Accessed 30 Mar 2025."},{"key":"6861_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrmicro.2016.193","volume":"15","author":"MC Field","year":"2017","unstructured":"Field MC, Horn D, Fairlamb AH, Ferguson MAJ, Gray DW, Read KD, et al. Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need. Nat Rev Microbiol. 2017;15:217\u201331.","journal-title":"Nat Rev Microbiol"},{"key":"6861_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/jeu.12184","volume":"62","author":"JA Urbina","year":"2015","unstructured":"Urbina JA. Recent clinical trials for the etiological treatment of chronic Chagas disease: advances, challenges and perspectives. J Eukaryot Microbiol. 2015;62:149\u201356.","journal-title":"J Eukaryot Microbiol"},{"key":"6861_CR4","first-page":"196","volume":"32","author":"AM Mej\u00eda-Jaramillo","year":"2012","unstructured":"Mej\u00eda-Jaramillo AM, Fern\u00e1ndez GJ, Montilla M, Nicholls RS, Triana-Ch\u00e1vez O. Trypanosoma cruzi strains resistant to benznidazole occurring in Colombia. Biomedica. 2012;32:196\u2013205.","journal-title":"Biomedica"},{"key":"6861_CR5","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nbt1267","volume":"24","author":"REW Hancock","year":"2006","unstructured":"Hancock REW, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol. 2006;24:1551\u20137.","journal-title":"Nat Biotechnol"},{"key":"6861_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00436-024-08133-0","volume":"123","author":"CL Hagemann","year":"2024","unstructured":"Hagemann CL, Macedo AJ, Tasca T. Therapeutic potential of antimicrobial peptides against pathogenic protozoa. Parasitol Res. 2024;123:122.","journal-title":"Parasitol Res"},{"key":"6861_CR7","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s00018-011-0720-8","volume":"68","author":"JM Conlon","year":"2011","unstructured":"Conlon JM. Structural diversity and species distribution of host-defense peptides in frog skin secretions. Cell Mol Life Sci. 2011;68:2303\u201315.","journal-title":"Cell Mol Life Sci"},{"key":"6861_CR8","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2741\/4461","volume":"21","author":"A Ladram","year":"2016","unstructured":"Ladram A, Nicolas P. Antimicrobial peptides from frog skin: biodiversity and therapeutic promises. Front Biosci. 2016;21:1341\u201371.","journal-title":"Front Biosci"},{"key":"6861_CR9","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.bbamem.2008.11.002","volume":"1788","author":"L Rivas","year":"2009","unstructured":"Rivas L, Luque-Ortega JR, Andreu D. Amphibian antimicrobial peptides and protozoa: lessons from parasites. Biochim Biophys Acta. 2009;1788:1570\u201381.","journal-title":"Biochim Biophys Acta"},{"key":"6861_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jprot.2016.06.017","volume":"146","author":"C Proa\u00f1o-Bola\u00f1os","year":"2016","unstructured":"Proa\u00f1o-Bola\u00f1os C, Zhou M, Wang L, Coloma LA, Chen T, Shaw C. Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer. J Proteomics. 2016;146:1\u201313.","journal-title":"J Proteomics"},{"key":"6861_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00726-021-02986-w","volume":"53","author":"SA Cuesta","year":"2021","unstructured":"Cuesta SA, Reinoso C, Morales F, Pilaquinga F, Mor\u00e1n-Marcillo G, Proa\u00f1o-Bola\u00f1os C, et al. Novel antimicrobial cruzioseptin peptides extracted from the splendid leaf frog, Cruziohyla calcarifer. Amino Acids. 2021;53:853\u201368.","journal-title":"Amino Acids"},{"key":"6861_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftaa053","volume":"78","author":"B Mendes","year":"2020","unstructured":"Mendes B, Proa\u00f1o-Bola\u00f1os C, Gadelha FR, Almeida JR, Miguel DC. Cruzioseptins, antibacterial peptides from Cruziohyla calcarifer skin, as promising leishmanicidal agents. Pathog Dis. 2020;78:ftaa053.","journal-title":"Pathog Dis"},{"key":"6861_CR13","doi-asserted-by":"publisher","first-page":"e03339","DOI":"10.1128\/spectrum.03339-23","volume":"12","author":"C Proa\u00f1o-Bola\u00f1os","year":"2024","unstructured":"Proa\u00f1o-Bola\u00f1os C, Mor\u00e1n-Marcillo G, de los Monteros-Silva NE, Berm\u00fadez-Puga S, Salazar MA, Blasco-Z\u00fa\u00f1iga A, et al. Bioactivity of synthetic peptides from Ecuadorian frog skin secretions against Leishmania mexicana, Plasmodium falciparum, and Trypanosoma cruzi. Microbiol Spectr. 2024;12:e03339-e3423.","journal-title":"Microbiol Spectr"},{"key":"6861_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.exppara.2010.02.006","volume":"126","author":"BS McGwire","year":"2010","unstructured":"McGwire BS, Kulkarni MM. Interactions of antimicrobial peptides with Leishmania and trypanosomes and their functional role in host parasitism. Exp Parasitol. 2010;126:397\u2013405.","journal-title":"Exp Parasitol"},{"key":"6861_CR15","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.3390\/ijms22094400","volume":"22","author":"AA Robles-Loaiza","year":"2021","unstructured":"Robles-Loaiza AA, Pinos-Tamayo EA, Mendes B, Teixeira C, Alves C, Gomes P, et al. Peptides to tackle leishmaniasis: current status and future directions. Int J Mol Sci. 2021;22:4400.","journal-title":"Int J Mol Sci"},{"key":"6861_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/biom13040599","volume":"13","author":"M Rojas-Pirela","year":"2023","unstructured":"Rojas-Pirela M, Kemmerling U, Qui\u00f1ones W, Michels PAM, Rojas V. Antimicrobial peptides (AMPs): potential therapeutic strategy against trypanosomiases? Biomolecules. 2023;13:599.","journal-title":"Biomolecules"},{"key":"6861_CR17","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1038\/s41467-024-51691-1","volume":"15","author":"JP Ulmschneider","year":"2024","unstructured":"Ulmschneider JP, Ulmschneider MB. Melittin can permeabilize membranes via large transient pores. Nat Commun. 2024;15:7281.","journal-title":"Nat Commun"},{"key":"6861_CR18","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.drudis.2022.02.018","volume":"27","author":"JC Alarcon-Barrera","year":"2022","unstructured":"Alarcon-Barrera JC, Kostidis S, Ondo-Mendez A, Giera M. Recent advances in metabolomics analysis for early drug development. Drug Discov Today. 2022;27:1763\u201373.","journal-title":"Drug Discov Today"},{"key":"6861_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita M, Sch\u00fctze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. ColabFold: making protein folding accessible to all. Nat Methods. 2022;19:679\u201382.","journal-title":"Nat Methods"},{"key":"6861_CR20","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605\u201312.","journal-title":"J Comput Chem"},{"key":"6861_CR21","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1590\/0074-0276130201","volume":"108","author":"LM Villa","year":"2013","unstructured":"Villa LM, Guhl F, Zabala D, Ram\u00edrez JD, Urrea DA, Hern\u00e1ndez DC, et al. The identification of two Trypanosoma cruzi I genotypes from domestic and sylvatic transmission cycles in Colombia based on a single polymerase chain reaction amplification of the spliced-leader intergenic region. Mem Inst Oswaldo Cruz. 2013;108:932\u20135.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"6861_CR22","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1590\/S0074-02762009000700021","volume":"104","author":"B Zingales","year":"2009","unstructured":"Zingales B, Andrade SG, Briones MRS, Campbell DA, Chiari E, Fernandes O, et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz. 2009;104:1051\u20134.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"6861_CR23","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/178308a0","volume":"178","author":"GJ Bone","year":"1956","unstructured":"Bone GJ, Steinert M. Isotopes incorporated in the nucleic acids of Trypanosoma mega. Nature. 1956;178:308\u20139.","journal-title":"Nature"},{"key":"6861_CR24","doi-asserted-by":"publisher","first-page":"1320154","DOI":"10.3389\/fmicb.2023.1320154","volume":"14","author":"S Berm\u00fadez-Puga","year":"2023","unstructured":"Berm\u00fadez-Puga S, Dias M, Freire de Oliveira T, Mendon\u00e7a CMN, de Almeida SRY, Rozas EE, et al. Dual antibacterial mechanism of [K4K15]CZS-1 against Salmonella typhimurium: a membrane active and intracellular-targeting antimicrobial peptide. Front Microbiol. 2023;14:1320154.","journal-title":"Front Microbiol"},{"key":"6861_CR25","doi-asserted-by":"publisher","first-page":"1206074","DOI":"10.3389\/fmolb.2023.1206074","volume":"10","author":"D Pardo-Rodriguez","year":"2023","unstructured":"Pardo-Rodriguez D, Lasso P, Santamar\u00eda-Torres M, Cala MP, Puerta CJ, M\u00e9ndez Arteaga JJ, et al. Clethra fimbriata hexanic extract triggers alteration in the energy metabolism in epimastigotes of Trypanosoma cruzi. Front Mol Biosci. 2023;10:1206074.","journal-title":"Front Mol Biosci"},{"key":"6861_CR26","doi-asserted-by":"publisher","first-page":"10038","DOI":"10.1021\/ac9019522","volume":"81","author":"T Kind","year":"2009","unstructured":"Kind T, Wohlgemuth G, Lee DY, Lu Y, Palazoglu M, Shahbaz S, et al. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography\/mass spectrometry. Anal Chem. 2009;81:10038\u201348.","journal-title":"Anal Chem"},{"key":"6861_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/metabo8020031","volume":"8","author":"I Bla\u017eenovi\u0107","year":"2018","unstructured":"Bla\u017eenovi\u0107 I, Kind T, Ji J, Fiehn O. Software tools and approaches for compound identification of LC-MS\/MS data in metabolomics. Metabolites. 2018;8:31.","journal-title":"Metabolites"},{"key":"6861_CR28","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/prot.22711","volume":"78","author":"K Lindorff-Larsen","year":"2010","unstructured":"Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO, et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins. 2010;78:1950\u20138.","journal-title":"Proteins"},{"key":"6861_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams CJ, Headd JJ, Moriarty NW, Prisant MG, Videau LL, Deis LN, et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 2018;27:293\u2013315.","journal-title":"Protein Sci"},{"key":"6861_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1529\/biophysj.107.106005","volume":"93","author":"G van den Bogaart","year":"2007","unstructured":"van den Bogaart G, Mika JT, Krasnikov V, Poolman B. The lipid dependence of melittin action investigated by dual-color fluorescence burst analysis. Biophys J. 2007;93:154\u201363.","journal-title":"Biophys J"},{"key":"6861_CR31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/membranes13030304","volume":"13","author":"N Calder\u00f3n-Rivera","year":"2023","unstructured":"Calder\u00f3n-Rivera N, M\u00fanera-Jaramillo J, Jaramillo-Berrio S, Suesca E, Manrique-Moreno M, Leidy C. Cardiolipin strongly inhibits the leakage activity of the short antimicrobial peptide ATRA-1 in comparison to LL-37, in model membranes mimicking the lipid composition of Staphylococcus aureus. Membranes. 2023;13:304.","journal-title":"Membranes"},{"key":"6861_CR32","doi-asserted-by":"publisher","first-page":"22346","DOI":"10.1016\/S0021-9258(18)54578-6","volume":"266","author":"Y Shai","year":"1991","unstructured":"Shai Y, Hadari YR, Finkels A. pH-dependent pore formation properties of pardaxin analogues. J Biol Chem. 1991;266:22346\u201354.","journal-title":"J Biol Chem"},{"key":"6861_CR33","volume":"12","author":"PC Kroon","year":"2024","unstructured":"Kroon PC, Grunewald F, Barnoud J, van Tilburg M, Souza PCT, Wassenaar TA, et al. Martinize2 and vermouth: unified framework for topology generation. Elife. 2024;12:RP90627.","journal-title":"Elife"},{"key":"6861_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0005-2736(81)90392-8","volume":"644","author":"JF Da Silveira","year":"1981","unstructured":"Da Silveira JF, Colli W. Chemical composition of the plasma membrane from epimastigote forms of Trypanosoma cruzi. Biochim Biophys Acta (BBA) Biomembr. 1981;644:341\u201350.","journal-title":"Biochim Biophys Acta (BBA) Biomembr"},{"key":"6861_CR35","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1021\/acs.jctc.5b00209","volume":"11","author":"TA Wassenaar","year":"2015","unstructured":"Wassenaar TA, Ing\u00f3lfsson HI, B\u00f6ckmann RA, Tieleman DP, Marrink SJ. Computational lipidomics with insane: a versatile tool for generating custom membranes for molecular simulations. J Chem Theory Comput. 2015;11:2144\u201355.","journal-title":"J Chem Theory Comput"},{"key":"6861_CR36","doi-asserted-by":"publisher","unstructured":"Lindahl, Abraham, Hess, van der Spoel. GROMACS Documentation release 2021. 2021. https:\/\/doi.org\/10.5281\/zenodo.4457591.","DOI":"10.5281\/zenodo.4457591"},{"key":"6861_CR37","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41592-021-01098-3","volume":"18","author":"PCT Souza","year":"2021","unstructured":"Souza PCT, Alessandri R, Barnoud J, Thallmair S, Faustino I, Gr\u00fcnewald F, et al. Martini 3: a general purpose force field for coarse-grained molecular dynamics. Nat Methods. 2021;18:382\u20138.","journal-title":"Nat Methods"},{"key":"6861_CR38","doi-asserted-by":"publisher","DOI":"10.1063\/1.2408420","volume":"126","author":"G Bussi","year":"2007","unstructured":"Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys. 2007;126:014101.","journal-title":"J Chem Phys"},{"key":"6861_CR39","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello M, Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys. 1981;52:7182\u201390.","journal-title":"J Appl Phys"},{"key":"6861_CR40","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/cem.1187","volume":"22","author":"L Eriksson","year":"2008","unstructured":"Eriksson L, Trygg J, Wold S. CV-ANOVA for significance testing of PLS and OPLS\u00ae models. J Chemom. 2008;22:594\u2013600.","journal-title":"J Chemom"},{"key":"6861_CR41","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.1111\/j.1742-4658.2009.07358.x","volume":"276","author":"A Mor","year":"2009","unstructured":"Mor A. Multifunctional host defense peptides: antiparasitic activities. FEBS J. 2009;276:6474\u201382.","journal-title":"FEBS J"},{"key":"6861_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2022.106675","volume":"236","author":"FA Santos","year":"2022","unstructured":"Santos FA, Cruz GS, Vieira FA, Queiroz BRS, Freitas CDT, Mesquita FP, et al. Systematic review of antiprotozoal potential of antimicrobial peptides. Acta Trop. 2022;236:106675.","journal-title":"Acta Trop"},{"key":"6861_CR43","doi-asserted-by":"publisher","first-page":"13818","DOI":"10.1038\/s41598-024-64691-4","volume":"14","author":"S Meraj","year":"2024","unstructured":"Meraj S, Dhari AS, Mohr E, Lowenberger C, Gries G. A novel prolixicin identified in common bed bugs with activity against both bacteria and parasites. Sci Rep. 2024;14:13818.","journal-title":"Sci Rep"},{"key":"6861_CR44","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.3390\/life13122339","volume":"13","author":"B Zingales","year":"2023","unstructured":"Zingales B, Macedo AM. Fifteen years after the definition of Trypanosoma cruzi DTUs: what have we learned? Life. 2023;13:2339.","journal-title":"Life"},{"key":"6861_CR45","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nrd2144","volume":"5","author":"S Nwaka","year":"2006","unstructured":"Nwaka S, Hudson A. Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov. 2006;5:941\u201355.","journal-title":"Nat Rev Drug Discov"},{"key":"6861_CR46","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1021\/acsinfecdis.2c00123","volume":"8","author":"J Mart\u00edn-Escolano","year":"2022","unstructured":"Mart\u00edn-Escolano J, Mar\u00edn C, Rosales MJ, Tsaousis AD, Medina-Carmona E, Mart\u00edn-Escolano R. An updated view of the Trypanosoma cruzi life cycle: intervention points for an effective treatment. ACS Infect Dis. 2022;8:1107\u201315.","journal-title":"ACS Infect Dis"},{"key":"6861_CR47","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1007\/s00436-018-6084-3","volume":"117","author":"C Fonseca-Berzal","year":"2018","unstructured":"Fonseca-Berzal C, Ar\u00e1n VJ, Escario JA, G\u00f3mez-Barrio A. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi. Parasitol Res. 2018;117:3367\u201380.","journal-title":"Parasitol Res"},{"key":"6861_CR48","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/mmi.15279","volume":"122","author":"MA Silva","year":"2024","unstructured":"Silva MA, Izidoro MA, Aric\u00f3 M, Juliano L, Schenkman S. The effect of nutritional and oxidative stress on the metabolome of Trypanosoma cruzi. Mol Microbiol. 2024;122:704\u201319.","journal-title":"Mol Microbiol"},{"key":"6861_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002844","volume":"8","author":"A Trochine","year":"2014","unstructured":"Trochine A, Creek DJ, Faral-Tello P, Barrett MP, Robello C. Benznidazole biotransformation and multiple targets in Trypanosoma cruzi revealed by metabolomics. PLoS Negl Trop Dis. 2014;8:e2844.","journal-title":"PLoS Negl Trop Dis"},{"key":"6861_CR50","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1140\/epjs\/s11734-024-01105-6","volume":"233","author":"S Karmakar","year":"2024","unstructured":"Karmakar S, Das S, Banerjee KK. Interaction of antimicrobial peptides with model membranes: a perspective towards new antibiotics. Eur Phys J Spec Top. 2024;233:2981\u201396.","journal-title":"Eur Phys J Spec Top"},{"key":"6861_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1017\/S0031182013000814","volume":"141","author":"DJ Creek","year":"2014","unstructured":"Creek DJ, Barrett MP. Determination of antiprotozoal drug mechanisms by metabolomics approaches. Parasitology. 2014;141:83\u201392.","journal-title":"Parasitology"},{"key":"6861_CR52","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/0022034516679973","volume":"96","author":"B Bechinger","year":"2017","unstructured":"Bechinger B, Gorr SU. Antimicrobial peptides: mechanisms of action and resistance. J Dent Res. 2017;96:254\u201360.","journal-title":"J Dent Res"},{"key":"6861_CR53","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.micron.2008.08.003","volume":"40","author":"RFS Menna-Barreto","year":"2009","unstructured":"Menna-Barreto RFS, Salom\u00e3o K, Dantas AP, Santa-Rita RM, Soares MJ, Barbosa HS, et al. Different cell death pathways induced by drugs in Trypanosoma cruzi: an ultrastructural study. Micron. 2009;40:157\u201368.","journal-title":"Micron"},{"key":"6861_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2021.183551","volume":"1863","author":"B Bertrand","year":"2021","unstructured":"Bertrand B, Gardu\u00f1o-Ju\u00e1rez R, Munoz-Garay C. Estimation of pore dimensions in lipid membranes induced by peptides and other biomolecules: a review. Biochim Biophys Acta Biomembr. 2021;1863:183551.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"6861_CR55","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.bbamem.2006.07.001","volume":"1758","author":"B Bechinger","year":"2006","unstructured":"Bechinger B, Lohner K. Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim Biophys Acta. 2006;1758:1529\u201339.","journal-title":"Biochim Biophys Acta"},{"key":"6861_CR56","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00232-023-00289-7","volume":"256","author":"C Has","year":"2023","unstructured":"Has C, Das SL. The functionality of membrane-inserting proteins and peptides: curvature sensing, generation, and pore formation. J Membr Biol. 2023;256:343\u201372.","journal-title":"J Membr Biol"},{"key":"6861_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2022.106759","volume":"282","author":"A Halder","year":"2022","unstructured":"Halder A, Karmakar S. An evidence of pores in phospholipid membrane induced by an antimicrobial peptide NK-2. Biophys Chem. 2022;282:106759.","journal-title":"Biophys Chem"},{"key":"6861_CR58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/1568026615666150703121700","volume":"16","author":"TH Lee","year":"2016","unstructured":"Lee TH, Hall KN, Aguilar MI. Antimicrobial peptide structure and mechanism of action: a focus on the role of membrane structure. Curr Top Med Chem. 2016;16:25\u201339.","journal-title":"Curr Top Med Chem"},{"key":"6861_CR59","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1126\/science.3883489","volume":"227","author":"AH Fairlamb","year":"1985","unstructured":"Fairlamb AH, Blackburn P, Ulrich P, Chait BT, Cerami A. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science. 1985;227:1485\u20137.","journal-title":"Science"},{"key":"6861_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.118569","volume":"398","author":"P Prabutzki","year":"2024","unstructured":"Prabutzki P, Schiller J, Engel KM. Phospholipid-derived lysophospholipids in (patho)physiology. Atherosclerosis. 2024;398:118569.","journal-title":"Atherosclerosis"},{"key":"6861_CR61","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1089\/ars.2009.2597","volume":"12","author":"VN Bochkov","year":"2010","unstructured":"Bochkov VN, Oskolkova OV, Birukov KG, Levonen AL, Binder CJ, St\u00f6ckl J. Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal. 2010;12:1009\u201359.","journal-title":"Antioxid Redox Signal"},{"key":"6861_CR62","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.toxicon.2017.02.031","volume":"130","author":"CP Mello","year":"2017","unstructured":"Mello CP, Lima DB, de Menezes RRPPB, Bandeira ICJ, Tessarolo LD, Sampaio TL, et al. Evaluation of the antichagasic activity of batroxicidin, a cathelicidin-related antimicrobial peptide found in Bothrops atrox venom gland. Toxicon. 2017;130:56\u201362.","journal-title":"Toxicon"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06861-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-06861-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06861-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T11:02:38Z","timestamp":1750417358000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-025-06861-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6861"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-06861-5","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by a local ethics committee (Comit\u00e9 de Bio\u00e9tica, Corporaci\u00f3n Universitaria Empresarial Alexander Humboldt, approval number: ACTA 014-31\/10\/2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"208"}}